| 182041 | 182041 | Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder | Completed | No Results Available | Overactive Bladder | Drug: Darifenacin|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00171184 |
| 182042 | 182042 | A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis | Completed | No Results Available | Beta-Thalassemia|Hemosiderosis | Drug: deferasirox | https://ClinicalTrials.gov/show/NCT00171171 |
| 182043 | 182043 | An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis | Completed | No Results Available | Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis | Drug: imatinib mesylate | https://ClinicalTrials.gov/show/NCT00171158 |
| 182044 | 182044 | A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder. | Completed | No Results Available | Overactive Bladder Syndrome | Drug: Darifenacin|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00171145 |
| 182045 | 182045 | VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women | Completed | No Results Available | Hypertension | Drug: valsartan|Drug: atenolol|Drug: hydrochlorothiazide | https://ClinicalTrials.gov/show/NCT00171132 |
| 182046 | 182046 | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril | Terminated | No Results Available | Hypertension|Diabetic Nephropathy | Drug: valsartan | https://ClinicalTrials.gov/show/NCT00171119 |
| 182047 | 182047 | Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure | Completed | No Results Available | Diastolic Dysfunction, Symptomatic Heart Failure | Drug: valsartan | https://ClinicalTrials.gov/show/NCT00171106 |
| 182048 | 182048 | A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia | Completed | No Results Available | Hypertension|Hypercholesterolemia | Drug: valsartan + simvastatin | https://ClinicalTrials.gov/show/NCT00171093 |
| 182049 | 182049 | VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis | Completed | No Results Available | Hypertension | Drug: valsartan|Drug: irbesartan | https://ClinicalTrials.gov/show/NCT00171080 |
| 182050 | 182050 | VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria | Completed | No Results Available | Hypertension | Drug: valsartan|Drug: lisinopril | https://ClinicalTrials.gov/show/NCT00171067 |
| 182051 | 182051 | Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension | Completed | Has Results | Hypertension | Drug: Valsartan 320 mg|Drug: Amlodipine 10 mg|Drug: Hydrochlorothiazide | https://ClinicalTrials.gov/show/NCT00171054 |
| 182052 | 182052 | A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age | Completed | No Results Available | Hypertension | Drug: valsartan | https://ClinicalTrials.gov/show/NCT00171041 |
| 182053 | 182053 | A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension | Completed | No Results Available | Hypertension | Drug: valsartan | https://ClinicalTrials.gov/show/NCT00171028 |
| 182054 | 182054 | VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil | Completed | No Results Available | Hypertension | Drug: valsartan plus hydrochlorothiazide | https://ClinicalTrials.gov/show/NCT00171015 |
| 182055 | 182055 | Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone | Completed | No Results Available | Hypertension | Drug: valsartan/amlodipine | https://ClinicalTrials.gov/show/NCT00171002 |
| 182056 | 182056 | Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone | Completed | No Results Available | Hypertension | Drug: valsartan plus hydrochlorothiazide | https://ClinicalTrials.gov/show/NCT00170989 |
| 182057 | 182057 | A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension | Completed | No Results Available | HYPERTENSION | Drug: valsartan + amlodipine | https://ClinicalTrials.gov/show/NCT00170976 |
| 182058 | 182058 | Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone | Completed | No Results Available | Hypertension | Drug: valsartan/amlodipine | https://ClinicalTrials.gov/show/NCT00170963 |
| 182059 | 182059 | Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension | Terminated | Has Results | Hypertension | Drug: Benazepril/amlodipine 20/5 mg - Dose Level 1 from Day 1 to Month 1|Drug: Benazepril/amlodipine 40/5 mg - Dose Level 2 from Month 1 to Month 2|Drug: Benazepril/amlodipine 40/10 mg - Dose Level 3 from Month 2 to Month 3 and thereafter|Drug: Benazepril/hydrochlorothiazide 20/12.5 mg - Dose Level 1 from Day 1 to Month 1|Drug: Benazepril/hydrochlorothiazide 40/12.5 mg - Dose Level 2 from Month 1 to Month 2|Drug: Benazepril/hydrochlorothiazide 40/25 mg - Dose Level 3 from Month 2 to Month 3 and thereafter | https://ClinicalTrials.gov/show/NCT00170950 |
| 182060 | 182060 | A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome | Completed | No Results Available | Metabolic Syndrome|Hypertension|Pre-Hypertension | Drug: valsartan plus hydrochlorothiazide | https://ClinicalTrials.gov/show/NCT00170937 |
| 182061 | 182061 | To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure. | Completed | No Results Available | Diastolic Dysfunction|Hypertension | Drug: Valsartan | https://ClinicalTrials.gov/show/NCT00170924 |
| 182062 | 182062 | Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. | Completed | No Results Available | Osteoporosis | Drug: AAE581 | https://ClinicalTrials.gov/show/NCT00170911 |
| 182063 | 182063 | Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain | Completed | No Results Available | Musculoskeletal Pain | Drug: Lumiracoxib | https://ClinicalTrials.gov/show/NCT00170898 |
| 182064 | 182064 | Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients | Completed | No Results Available | Kidney Transplantation | Drug: Everolimus | https://ClinicalTrials.gov/show/NCT00170885 |
| 182065 | 182065 | 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis | Completed | No Results Available | Osteoarthritis|Rheumatoid Arthritis | Drug: Lumiracoxib | https://ClinicalTrials.gov/show/NCT00170872 |
| 182066 | 182066 | Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients | Completed | No Results Available | Heart Transplantation | Drug: Everolimus | https://ClinicalTrials.gov/show/NCT00170859 |
| 182067 | 182067 | ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients | Completed | Has Results | Renal Transplantation | Drug: Everolimus (RAD001)|Drug: Calcineurin Inhibitors (CNI)|Drug: Mycophenolate acid (MPA)/Azathioprine (AZA)|Drug: Steroids | https://ClinicalTrials.gov/show/NCT00170846 |
| 182068 | 182068 | Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients | Completed | No Results Available | Renal Transplantation | Drug: Everolimus | https://ClinicalTrials.gov/show/NCT00170833 |
| 182069 | 182069 | Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen | Completed | No Results Available | Renal Transplantation | Drug: Everolimus | https://ClinicalTrials.gov/show/NCT00170820 |
| 182070 | 182070 | Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients. | Completed | No Results Available | Cardiac Transplantation | Drug: Everolimus (RAD001) | https://ClinicalTrials.gov/show/NCT00170794 |